Abiopharma

🔍 Alonso Sanchez Maria del Dado (Executive)

Company: Nebius Group N.V. (NBIS)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 470 shares of Class A Shares at $196.0 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,202.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.
• REMARKS: Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Act, the reporting person's transactions in the issuer's equity securities are exempt from Sections 16(b) and 16(c) of the Act.